Skip to content
Research Article Open access CC BY 4.0

Coexistance of Masked Philadelphia Chromosome and BCR-ABL1 Rearrangement with JAK2 (V617F) Point Mutation-A Case Report

Semir Mešanović, Haris Šahović, Goran Šarkanović

International Journal of Medical and Pharmaceutical Case Reports · pp. 1–7 · Published 9 Dec 2015

10.9734/IJMPCR/2016/22951

Abstract

In accordance with the last World Health Organization (WHO) classification, myeloproliferative neoplasms (MPNs) are classified on the basis of the presence or absence of BCR-ABL1 gene transcript, or the presence or absence of Philadelphia chromosome (Ph) in the karyotype. Previously, from a diagnostics perspective, it was thought that the JAK2V617F point mutation and BCR-ABL1 rearrangement were used to differentiate and unmask chronic myelogenous leukemia (CML) from other MPNs (and vice versa). In contradiction with this opinion, to date, several cases with the coexistence of BCR-ABL1 fusion gene and JAK2V617F mutation in bone marrow and blood samples has been reported. With this case study we report  a rare case of essential thrombocytemia with masked Philadelphia chromosome harboring both BCR-ABL1 rearrangement and JAK2V617F point mutation, simultaneously.

BCR-ABL1 Chronic Myelogenous Leukemia (CML) Essential Thrombocytemia (ET) JAK2V617F philadelphia chromosome.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.